Clinical Trials Sponsored by AnYxis Immuno-Oncology GmbH
Total 1 results
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology... and other collaboratorsSuspended
Sponsors and Collaborators
- Etablissement Publique de Santé Mentale de la Réunion
- Diabetech
- First Hospital Affiliated to Baotou Medical College, Baotou, China
- Uzès hospital
- ViiV Healthcare Australia Pty. Ltd
- Pyrotech Therapeutics, Inc.
- MRC/UVRI & LSHTM Uganda Research Unit
- Ministry of Tourism, Sport and the Arts, British Columbia
- PharmTest s.r.o.
- Centre de Pharmacologie Clinique, INSERM CIC 501
- Marta Camats Terre
- Jadran Galenski laboratorij d.d.Rijeka
- Medtronic Poland Spółka z ograniczoną odpowiedzialnością
- Institutos Nacionales de Salud, USA Instituto Alemán del Cáncer
- Incept BioSystems, Inc.
- Medical School University of Zagreb
- Vaxxinity, Inc.
- CK-CARE (Christine Kühne - Center for Allergy Research and Education)
- Tianjin Medical University
- St. Louis Children's Hospital
- View Full List
Medical Conditions
- Nonarthritic Hip Disease
- Non-sedentary
- Central Centrifugal Cicatricial Alopecia (CCCA)
- Well-trained Athletes
- Repository Corticotropin Injection
- Post-Cerebrovascular Accident (CVA) Hemiparesis
- Vomit
- Fenofibrate
- Vasomotor Symptoms Associated With Menopause
- High Turnover Bone Disease
- Pulpotomy of Young Permanent Molars
- Human Papilloma Virus Infection
- Relapsed Malignant Solid Tumor
- Hepatitis C, Treatment Naïve, Genotype 1 Patients
- Oral Allergic Syndrome
- Family Functioning
- Neoplasms, Advanced Solid
- Native and Valve in Valve Aortic Valve Failure
- Breast Cancer Treatment
- Critical Illness Sepsis, Severe
- View Full List
Drug Interventions
- ASP2151
- RoActemra sc
- 40 consecutive doses of SUF NT 15 mcg taken every 20 minutes
- Phenelzine Sulfate
- Tamsulosin
- SPLA2 Inhibitor
- 0.45% saline in 5% dextrose (intravenous)
- Oxaliplatin
- Durvalumab
- Keytruda
- Famciclovir
- Prazosin
- Ropivacaine 0.2%
- Sulfasalazine
- Experimental DW224aa
- SHR-1210
- Olorofim
- Weak steroid (Flurolon, Allergan)
- Lidocaine
- Carboplatin
- View Full List
CROs by country
- Contract Research Organizations in Chile
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Greece
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Pakistan
- Contract Research Organizations in Poland
- Contract Research Organizations in Romania
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Slovenia
- Contract Research Organizations in Spain
- Contract Research Organizations in United Kingdom
- CRO list by country